#tweetorial 🧵
🚩AL & MM - Transcriptional patterns link common causal root with differing behaviours
(1/14)
➡️Light-chain amyloidosis (AL) and multiple myeloma (MM), are plasma cell (PC) malignancies with strikingly different clinical presentations 🥼🩺
➡️Success in🎯identifying these mechanisms has thus far been limited 👎
(2/14)
➡️Alameda et al define a “transcriptional atlas” of normal PCs, AL amyloidosis, MM, and MGUS, identifying 13 different transcriptional patterns linking distinct PC dyscrasias to subsets of normal developing PCs, with diagnostic 🔬and prognostic implications
(3/14)
➡️This is the☝️first integrated bulk and single-cell analysis of the transcriptional programs of anatomically different normal PC subsets vs tumour PCs in AL, MM, and MGUS.👇
(4/14)
👉💯 subjects were studied
Normal PCs were isolated by fluorescence-activated cell sorting (FACS) from SLOs and PB according to immunoglobulin heavy-chain isotypes, as well as from BM samples of healthy adults according to differential expression of CD19, CD39, CD56,&CD81
(5/14)
👉Tumor PCs were isolated by FACS from BM samples of patients with AL (n = 32), MGUS (n = 6), and MM (n = 32).
👉Ectoenzyme CD39 as a discriminatory biomarker of newborn BM-PCs.
(6/14)
➡️Tumour PCs express TPs linked to various stages of normal PC differentiation
➡️Nonsuperimposable distribution of tumour PCs from AL, MM, and MGUS patients 😷throughout the various stages of normal PC development
(7/14)
➡️TPs from SLOs, PB, and newborn and long-lived BM-PCs were equally distributed in MGUS, there was a predominant expression of TPs from SLO-PCs in AL and TPs from PB- plus newborn BM-PCs in MM
(8/14)
➡️AL patients with tumour PCs displaying ⚡️higher NES values corresponding to normal SLO-PCs had significantly 🔽inferior progression-free survival
(9/14)
➡️What is known?🔖
👉📌AL and MM share a common causal root, namely, the presence of clonal malignant plasma cells in the bone marrow, but the behaviour of these cells differ
(10/14)
👉📌In AL, the clonal plasma cells do not accumulate but induce the deposition of light chains in various organs
👉📌In MM, clonal plasma cells accumulate in the bone marrow, leading to harmful effects.
(11/14)
➡️What is unknown?🧐🔍
👉Mechanisms identifying differences in these plasma cell disorders is limited.
(12/14)
➡️New Knowledge Generated 🔓🗝️
👉A predominant TP from SLO-PCs was expressed in AL, and from both PB-PCs and newborn BM-PCs in MM
👉TPs related to germinal centre formation & B-cell activation/proliferation were turned off once normal PCs exited from SLOs(TP-3 & TP-4)
(13/14)
👉Genes related to NF-kB, were turned on from the moment PCs left SLOs
👉Impaired ribosome machinery in AL
(14/14)
➡️Take-Home📤🥡🏡
Tumour cells in light-chain amyloidosis and myeloma show different transcriptional rewiring of normal plasma cell development.
🛑⏱️END OF #TWEETORIAL!!
🙏Please RT and 👍Like if you enjoyed reading this :)
Follow us for more such #tweetorial 🏃🏃♂️🏃♀️
References: 1. Corre, J. (2021). Why is amyloidosis not multiple myeloma?. Blood, 138(17), 1514-1515. doi.org/10.1182/blood.…
2. Alameda, D., Goicoechea, I., Vicari, M., Arriazu, E., Nevone, A., & Rodriguez, S. et al. (2021). Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development. Blood, 138(17), 1583-1589. doi.org/10.1182/blood.…
#tweetorial 🧵
🚩Metabolism and Acute Myeloid Leukemia
(1/23)
➡️📈🔎Increased attention over the last decade on the metabolic perturbations in AML
➡️Potential therapeutic implications – with ‘druggable’ targets
(2/23)
➡️🗒️📌Summary of recent concepts
🔊IT IS ALL HAPPENING IN THE MITOCHONDRIA
👉📈🏹Increase potential of targeting the mitochondria
👉🦀Anti-cancer agents specifically targeting cancer cell mitochondria are referred to as 'mitocans'
(3/23)
➡️Metabolic adaptions of AML cells
AML is a 🦀cancer derived from the myeloid lineage of blood🩸cells, characterized by overproduction of malignant cells.
👉A provisional entity in the 2016 World Health Organization classification of acute leukemia 🩸🩸
👉Gene expression 🧬signature similar to Ph-positive ALL but lacks the BCR-ABL1 translocation @NancyArthurPhD
➡️Originally defined by gene expression 🧬profiling in 2009 by 2 groups
👉Children's Oncology Group (COG) and St. Jude Children's Research Hospital (referred to as Ph-like ALL) 👉Dutch Childhood Oncology Group (referred to as BCR-ABL1-like ALL) – DCOG/COALL
👉The differences in the approaches are outlined in the figure; more on the gene expression 🧬 signatures and diagnostic conundrums later!